Have a personal or library account? Click to login
On the relationship between CT measured abdominal fat parameters and three metabolic risk biomarkers Cover

On the relationship between CT measured abdominal fat parameters and three metabolic risk biomarkers

By: Marian Pop and  Raluca Monica Pop  
Open Access
|Feb 2023

References

  1. 1. WHO. Cardiovascular diseases [Internet]. [cited 2022 Dec 20]. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
  2. 2. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke. Circulation. 2016 Jun 7;133(23):e674-90. DOI: 10.1161/CIR.000000000000039527162236
  3. 3. Fan H, Li X, Zheng L, Chen X, lan Q, Wu H, et al. Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese. Sci Rep. 2016 Aug 17;6(1):21521. DOI: 10.1038/srep21521475633126882876
  4. 4. Wilding JPH, Jacob S. Cardiovascular outcome trials in obesity: A review. Obesity Reviews. 2021 Jan 7;22(1). DOI: 10.1111/obr.1311232893459
  5. 5. Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018 Sep 1;21(5):360-5. DOI: 10.1097/MCO.0000000000000485629945029916924
  6. 6. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020 Mar 4;16(3):177-89. DOI: 10.1038/s41574-019-0310-7702797032020062
  7. 7. Neeland IJ, Ross R, Després J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019 Sep 1;7(9):715-25. DOI: 10.1016/S2213-8587(19)30084-131301983
  8. 8. Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Circ Res. 2021 Apr 2;128(7):951-68. DOI: 10.1161/CIRCRESAHA.121.318093802627233793327
  9. 9. Després JP. Abdominal obesity and cardiovascular disease: is inflammation the missing link? Can J Cardiol. 2012 Nov;28(6):642-52. DOI: 10.1016/j.cjca.2012.06.00422889821
  10. 10. Linder N, Michel S, Eggebrecht T, Schaudinn A, Blüher M, Dietrich A, et al. Estimation of abdominal subcutaneous fat volume of obese adults from single-slice MRI data - Regression coefficients and agreement. Eur J Radiol. 2020 Sep 1;130:109184. DOI: 10.1016/j.ejrad.2020.10918432712498
  11. 11. Xu Z, Liu Y, Yan C, Yang R, Xu L, Guo Z, et al. Measurement of visceral fat and abdominal obesity by single-frequency bioelectrical impedance and CT: a cross-sectional study. BMJ Open. 2021 Oct 11;11(10):e048221. DOI: 10.1136/bmjopen-2020-048221850685434635516
  12. 12. Chen S, Ma D, Su D, Li Y, Yu X, Jiang Y, et al. The Optimal Axial Anatomical Site for a Single-Slice Area to Quantify the Total Volume of Visceral Adipose Tissue in Quantitative CT. Front Endocrinol (Lausanne). 2022 Jun 23;13. DOI: 10.3389/fendo.2022.870552925994335813654
  13. 13. Pop RM, Pop M, Dogaru G, Bacarea VC. A web-based nutritional assessment tool. Studies in Informatics and Control. 2013;22(2):307-14. DOI: 10.24846/v22i3y201307
  14. 14. Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, García-Ruiz JM, Mendiguren J, et al. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017 Dec 19;70(24):2979-91. DOI: 10.1016/j.jacc.2017.10.02429241485
  15. 15. Poznyak A v, Litvinova L, Poggio P, Sukhorukov VN, Orekhov AN. Effect of Glucose Levels on Cardiovascular Risk. Cells. 2022 Sep 28;11(19):3034. DOI: 10.3390/cells11193034956287636230996
  16. 16. Park C, Guallar E, Linton JA, Lee D-C, Jang Y, Son DK, et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care. 2013 Jul 1;36(7):1988-93. DOI: 10.2337/dc12-1577368730423404299
  17. 17. Farnier M, Zeller M, Masson D, Cottin Y. Triglycerides and risk of atherosclerotic cardiovascular disease: An update. Arch Cardiovasc Dis. 2021 Feb 1;114(2):132-9. DOI: 10.1016/j.acvd.2020.11.00633546998
  18. 18. Ye X, Kong W, Zafar MI, Chen L-L. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019 Apr 15;18(1):48. DOI: 10.1186/s12933-019-0851-z646665830987625
  19. 19. Conget I, Giménez M. Glucose Control and Cardiovascular Disease. Diabetes Care. 2009 Nov 1;32(suppl_2):S334-6. DOI: 10.2337/dc09-S334281144919875576
  20. 20. Harchaoui K, Visser M, Kastelein J, Stroes E, Dallinga-Thie G. Triglycerides and Cardiovascular Risk. Curr Cardiol Rev. 2009 Aug 1;5(3):216-22. DOI: 10.2174/157340309788970315282214420676280
  21. 21. McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep. 2008 Oct 16;10(5):386-90. DOI: 10.1007/s11883-008-0060-918706279
  22. 22. Park G-M, Cho Y-R, Won K-B, Yang YJ, Park S, Ann SH, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020 Jan 14;19(1):7. DOI: 10.1186/s12944-020-1187-0696124031937313
  23. 23. Tao L-C, Xu J, Wang T, Hua F, Li J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022 Dec 6;21(1):68. DOI: 10.1186/s12933-022-01511-x907801535524263
  24. 24. Pop M, Pop R. ECR 2014, Part B. Insights Imaging. 2014 Mar 27;5(S1):135-368. DOI: 10.1007/s13244-014-0317-5394818124573559
  25. 25. SJÖSTRÖM L, KVIST H. Regional body fat measurements with CT-scan and evaluation of anthropometric predictions. Acta Med Scand Suppl. 1988;723(723 S):169-77. DOI: 10.1111/j.0954-6820.1987.tb05941.x3164964
  26. 26. Rasband WS. ImageJ [Internet]. U. S. National Institutes of Health, Bethesda, Maryland, USA; Available from: https://imagej.nih.gov/ij/
  27. 27. Ciudin A, Salvador R, Budoy A, Ciudin A, Spinu C, Diaconu MG, et al. Measurement of waist circumference for retrospective studies - prospective validation of use of CT images to assess abdominal circumference. Endocrinol Nutr. 2014 Mar;61(3):147-52. DOI: 10.1016/j.endonu.2013.10.00424342428
  28. 28. Villarino MB. Ramanujan’s Perimeter of an Ellipse. 2005;
  29. 29. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Dec 1;6(4):299-304. DOI: 10.1089/met.2008.003419067533
  30. 30. IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.; 2017.
  31. 31. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007 Jul;116(1):39-48. DOI: 10.1161/CIRCULATIONAHA.106.67535517576866
  32. 32. Kvist H, Chowdhury B, Sjostrom L, Tylen U, Cederblad A. Adipose tissue volume determination in males by computed tomography and 40K. Int J Obes. 1988;12(3):249-66.
  33. 33. Enzi G, Gasparo M, Raimondo Biondetti P, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. American Journal of Clinical Nutrition. 1986;44(6):739-46. DOI: 10.1093/ajcn/44.6.7393788827
  34. 34. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999 Apr 1;211(1):283-6. DOI: 10.1148/radiology.211.1.r99ap1528310189485
  35. 35. Després J-P. Body Fat Distribution and Risk of Cardiovascular Disease. Circulation. 2012 Sep 4;126(10):1301-13. DOI: 10.1161/CIRCULATIONAHA.111.06726422949540
  36. 36. Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012 Feb 22;44(1):82-92. DOI: 10.3109/07853890.2010.52613820964583
  37. 37. Anderson PJ, Chan JCN, Chan YL, Tomlinson B, Young RP, Lee ZSK, et al. Visceral Fat and Cardiovascular Risk Factors in Chinese NIDDM Patients. Diabetes Care. 1997 Dec 1;20(12):1854-8. DOI: 10.2337/diacare.20.12.18549405906
  38. 38. Saito K, Shimamoto T, Takahashi Y, Okushin K, Takahashi M, Masuda Y, et al. Gender-specific factors contributing to visceral obesity including the sleep-obesity relationship: a large-scale cross-sectional study from East Asia. Sci Rep. 2022 Nov 24;12(1):20318. DOI: 10.1038/s41598-022-24863-6970070136434061
  39. 39. Sukkriang N, Chanprasertpinyo W, Wattanapisit A, Punsawad C, Thamrongrat N, Sangpoom S. Correlation of body visceral fat rating with serum lipid profile and fasting blood sugar in obese adults using a noninvasive machine. Heliyon. 2021 Feb 1;7(2):e06264. DOI: 10.1016/j.heliyon.2021.e06264789343333644479
  40. 40. Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013 Jan 1;93(1):359-404. DOI: 10.1152/physrev.00033.201123303913
  41. 41. Leenen R, van der Kooy K, Seidell JC, Deurenberg P. Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women. Atherosclerosis. 1992 Jun 1;94(2-3):171-81. DOI: 10.1016/0021-9150(92)90242-91632871
  42. 42. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr. 1990 Jun 1;51(6):953-7. DOI: 10.1093/ajcn/51.6.9532349931
  43. 43. Nemoto M, Yeernuer T, Masutani Y, Nomura Y, Hanaoka S, Miki S, et al. Development of Automatic Visceral Fat Volume Calculation Software for CT Volume Data. J Obes. 2014;2014:1-7. DOI: 10.1155/2014/495084398148724782922
  44. 44. Kim SS, Kim J-H, Jeong WK, Lee J, Kim YK, Choi D, et al. Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography. Medicine. 2019 May 1;98(22):e15867. DOI: 10.1097/MD.0000000000015867670881231145342
  45. 45. Yi W, Kim K, Im M, Ryang S, Kim EH, Kim M, et al. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors. Sci Rep. 2022 Jan 10;12(1):387. DOI: 10.1038/s41598-021-04402-5874843235013484
  46. 46. Wendler G, Nassif PAN, Malafaia O, Wendler E, Wendler IBT, Cirpiani LM. HELICAL COMPUTERIZED TOMOGRAPHY CAN MEASURE SUBCUTANEOUS, VISCERAL AND TOTAL FAT AREAS? Arq Bras Cir Dig. 2022;34(3):e1591. DOI: 10.1590/0102-672020210003e1591873526535019117
DOI: https://doi.org/10.2478/rrlm-2023-0005 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 51 - 58
Submitted on: Dec 21, 2022
|
Accepted on: Jan 7, 2023
|
Published on: Feb 8, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Marian Pop, Raluca Monica Pop, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.